Valion BioVBIO
13F holders, Q2 2025 (June 30)4holders +2
2new positions
0sold out
$4.15avg. 13F price*
At the end of Q2 2025, 4 institutions reported holding Valion Bio Inc. (VBIO) in their 13F filings, up 2 from Q1 2025. 2 opened new positions and 0 sold out. The largest holders were Marex Group Ltd ($163K), UBS Group AG ($23K) and SBI Securities Co., Ltd. ($66).
- Company
- Valion Bio Inc.
- Filed as
- TIVIC HEALTH SYSTEMS INC (Q2 2025)
- CUSIP
- 888705308
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $186K |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 44,940 shares bought, net +44,940 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Marex Group Ltd | 0.00% | New | 39,283 | $163K |
| UBS Group AG | 0.00% | New | 5,653 | $23K |
| SBI Securities Co., Ltd. | 0.00% | No change | 16 | $66 |
| Bank of America Corp. | 0.00% | Add +80.0% | 9 | $37 |
"% of holder's portfolio" is VBIO's weight in each manager's 13F, not the share of Valion Bio Inc. the manager owns.